Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis
Study sponsor: Aclaris Therapeutics, Inc. · ACRS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2021-04-08Actual
Enrollment · participants50Actual
Source updated2023-09-28Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.